feed,title,long_url,short_url
SeekingAlpha,Aldeyra Therapeutics stock rises 21% on Q2 beat with eyes on approval path for reproxalap,https://seekingalpha.com/news/3868288,
SeekingAlpha,"AstraZeneca, Daiichi Sankyo's Enhertu approved for HER2-low breast cancer",https://seekingalpha.com/news/3868252,
